American Journal of Obstetrics & Gynecology (2019 IF: 6.502) , “The Gray Journal”, covers the full spectrum of Obstetrics and Gynecology. The aim of the Journal is to publish original research (clinical and translational), reviews, opinions, video clips, podcasts and interviews that will have an impact on the understanding of health and disease and that has the potential to change the practice of women’s health care. An important focus is the diagnosis, treatment, prediction and prevention of obstetrical and gynecological disorders. The Journal also publishes work on the biology of reproduction, and content which provides insight into the physiology and mechanisms of obstetrical and gynecological diseases.
American Journal of Obstetrics & Gynecology: latest articles
- Maternal serum levels of sFlt-1 and PlGF at 20 and 28 weeks of gestational age and the risk of spontaneous preterm birth
- Randomized controlled trial of pre-pregnancy lifestyle intervention to reduce recurrence of gestational diabetes
- Early pregnancy prediction of preeclampsia with metabolite biomarkers：Still at the bench
- Exploring the impact of COVID-19 on gestational age at the time of abortion: An interrupted time series analysis among patients receiving abortions in Southwest California
- A Step Closer to Utilising Metabolite Biomarkers to Improve Early Pregnancy Prediction of Preeclampsia.
- Predicted changes in travel distance for abortion among counties with low rates of effective contraceptive use following Dobbs v Jackson
- Society for Maternal-Fetal Medicine Special Statement: Curriculum outline on patient safety and quality for maternal-fetal medicine fellows
- Extended interval gentamicin dosing in obstetrics
- Patterns of nucleic acid amplification testing among women with incident versus prevalent diagnoses of vaginitis
- Delta variant neutralizing antibody response following maternal COVID19 vaccination
- Estimated time to relief from vulvovaginal symptoms with ibrexafungerp: patient reported data from the VANISH studies
- A pilot study of uterine fibroids and longitudinal profiles of the vaginal microbiota among a cohort presenting for transvaginal ultrasound
- Integrated prenatal and hepatitis c virus care increases linkage
- COVID-19 and indications for delivery: a prospective cohort study
- Reactogenicity, SARS-cov-2 infection, and pregnancy outcomes following COVID-19 vaccination during pregnancy in canada
- Using hierarchical cluster analysis to evaluate attitudes toward menstrual suppression among kenyan women using a contraceptive vaginal ring (CVR)
- Metabolic contributions of vaginal lactobacilli species to the cervicovaginal environment utilizing human 3d cervical epithelial cell models
- Developing sentinel surveillance for chlamydia, gonorrhea, and trichomonas using test results from routine screening during pregnancy
- Glycogen-Degrading pullulanase a is variably present and correlated with lactic acid in vaginal samples from young african women
- COVID-19 vaccine uptake, vaccine confidence and medical mistrust among reproductive-aged women in jamaica
- Genotypic and phenotypic differences supporting the recently described species split between lactobacillus jensenii and lactobacillus mulieris
- Safety and savings from penicillin allergy de-labelling in pregnancy: good stewardship, good cents
- Condomless vaginal intercourse and lubricant use are independently associated with antioxidants within the vaginal tract
- Pregnancy outcomes by pandemic wave among pregnant individuals with COVID-19 infection
- Understanding factors shaping vaccination decisions among pregnant or lactating individuals, or those planning a pregnancy in a canadian province
- Long-Term observations of oteseconazole efficacy against recurrent vulvovaginal candidiasis
- Oteseconazole for RVVC in diabetes: post-hoc analysis of safety and clinical response in phase 3 studies
- A phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of once monthly oral ibrexafungerp for prevention of recurrent vulvovaginal candidiasis (VVC)
- Delivery and neonatal outcomes of women critically ill with COVID-19
- Identification of trichomonas vaginalis 5-nitroimidazole resistance targets to inform future drug development